ZA200904654B - Tablet formulation - Google Patents

Tablet formulation

Info

Publication number
ZA200904654B
ZA200904654B ZA200904654A ZA200904654A ZA200904654B ZA 200904654 B ZA200904654 B ZA 200904654B ZA 200904654 A ZA200904654 A ZA 200904654A ZA 200904654 A ZA200904654 A ZA 200904654A ZA 200904654 B ZA200904654 B ZA 200904654B
Authority
ZA
South Africa
Prior art keywords
tablet formulation
formulation
tablet
Prior art date
Application number
ZA200904654A
Other languages
English (en)
Inventor
Karthigeyan Nanjan
Alawi Fadil Al
Wayne Frederick Leech
Man Yik Li
Steve Li
Original Assignee
Bomac Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomac Research Ltd filed Critical Bomac Research Ltd
Publication of ZA200904654B publication Critical patent/ZA200904654B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200904654A 2006-12-21 2009-07-02 Tablet formulation ZA200904654B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ552290A NZ552290A (en) 2006-12-21 2006-12-21 Tablet fomulation

Publications (1)

Publication Number Publication Date
ZA200904654B true ZA200904654B (en) 2010-09-29

Family

ID=39536842

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904654A ZA200904654B (en) 2006-12-21 2009-07-02 Tablet formulation

Country Status (7)

Country Link
US (1) US8835397B2 (pt)
AU (1) AU2007334742B2 (pt)
BR (1) BRPI0721154A2 (pt)
GB (1) GB2458593C2 (pt)
NZ (1) NZ552290A (pt)
WO (1) WO2008075979A2 (pt)
ZA (1) ZA200904654B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0822980A2 (pt) * 2008-07-29 2015-06-23 Bomac Research Ltd Método de fabricação de tabuleta
CN106138022A (zh) * 2009-09-07 2016-11-23 晶源集团有限公司 含有超微粒化十六酰胺乙醇的组合物
CN105213337A (zh) * 2015-10-15 2016-01-06 四川成邦药业有限公司 兽用阿苯达唑分散片及其制备方法
US11147273B2 (en) 2017-06-26 2021-10-19 Boehringer Ingelheim Animal Health USA Inc. Dual active parasiticidal granule compositions, methods and uses thereof
CN110151910A (zh) * 2019-05-28 2019-08-23 石家庄九鼎动物药业有限公司 一种兽用抗寄生虫药物阿苯达唑伊维菌素片及其制备方法
CN111067875B (zh) * 2020-01-16 2021-11-30 兰州大学 一种阿苯达唑液固压缩片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389397A (en) * 1980-08-04 1983-06-21 Merck & Co., Inc. Solubilization of ivermectin in water
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
DE10117993A1 (de) * 2001-04-10 2002-10-17 Clariant Gmbh Pestizidzubereitungen enthaltend Copolymere
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
WO2003011214A2 (en) 2001-07-31 2003-02-13 Royer Biomedical, Inc. Novel methods and formulations for administration of active agents
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7582612B2 (en) * 2004-03-12 2009-09-01 Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2006036625A2 (en) 2004-09-24 2006-04-06 The Hartz Mountain Corporation Encapsulated pharmaceutical agents

Also Published As

Publication number Publication date
GB2458593A (en) 2009-09-30
GB2458593C2 (en) 2012-04-04
NZ552290A (en) 2009-05-31
WO2008075979A2 (en) 2008-06-26
AU2007334742B2 (en) 2012-08-30
WO2008075979A3 (en) 2008-07-31
GB2458593C (en) 2011-10-12
AU2007334742A1 (en) 2008-06-26
BRPI0721154A2 (pt) 2014-04-01
US8835397B2 (en) 2014-09-16
GB2458593B (en) 2011-05-04
US20100016248A1 (en) 2010-01-21
GB0911061D0 (en) 2009-08-12

Similar Documents

Publication Publication Date Title
GB0608098D0 (en) Formulation
GB2450753B (en) New Pharmaceutical formulation
EP1992348A4 (en) PHARMACEUTICAL COMBINATION
GB0612671D0 (en) Nutritional formulation
EP2025337A4 (en) EXTERNAL PHARMACEUTICAL COMPOSITION
EP2005959A4 (en) EXTERNAL PHARMACEUTICAL COMPOSITION
EP2005958A4 (en) TOPICAL PHARMACEUTICAL COMPOSITION
GB0614586D0 (en) Pharmaceutical Formulation
ZA200808194B (en) Granular Formulation
ZA201004439B (en) Formulation
IL240780A0 (en) Nutritional formulation
SI2040684T1 (sl) Večenotne tablete
GB0625312D0 (en) Formulation
GB0625095D0 (en) Formulation
GB0707463D0 (en) Formulation
ZA200904654B (en) Tablet formulation
EP2057985A4 (en) DRAGEE
EP2124959A4 (en) PHARMACEUTICAL COMPOSITION
GB0605104D0 (en) Tablet dispenser
IL198160A0 (en) Pharmaceutical formulations
GB0612809D0 (en) Formulation
GB0715723D0 (en) Formulation
GB0712972D0 (en) Formulation
GB0608465D0 (en) Tablet dispenser
EP2050456A4 (en) COMPRESSED